Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|10|1850-1859

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.10, 2013-03, pp. : 1850-1859

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-1 RT Nonnucleoside Inhibitors and Their Interaction with RT for Antiviral Drug Development

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 391-413

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Interactions with Cholinesterase Inhibitors

By Defilippi J.L.  

Drugs & Aging, Vol. 20, Iss. 6, 2003-01 ,pp. : 437-444

Adis International

Access to resources Recommend Favorite

Drug Interactions of HIV Protease Inhibitors

By Malaty L.I.  

Drug Safety, Vol. 20, Iss. 2, 1999-02 ,pp. : 147-169

Adis International

Access to resources Recommend Favorite

Drug interactions with cholinesterase inhibitors reviewed

By  

Inpharma, Vol. 1, Iss. 1411, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Dipeptidylpeptidase-4 Inhibitors (Gliptins): Focus on Drug-Drug Interactions

By Scheen André J.  

Clinical Pharmacokinetics, Vol. 49, Iss. 9, 2010-09 ,pp. : 573-588

Adis International

Access to resources Recommend Favorite